About Duke Human Vaccine Institute - Duke Vaccine and Trials Unit
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Duke Human Vaccine Institute - Duke Vaccine and Trials Unit
During the past decade, Duke Human Vaccine Institute - Duke Vaccine and Trials Unit conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 13 clinical trials were completed, i.e. on
average, 54.2% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 12 clinical trials were completed. i.e. 80%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Duke Human Vaccine Institute - Duke Vaccine and Trials Unit"
#1 collaborator was "Pfizer" with 4 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Duke Human Vaccine Institute - Duke Vaccine and Trials Unit
According to Clinical.Site data, the most researched conditions in "Duke Human Vaccine Institute - Duke Vaccine and Trials Unit" are
"COVID-19" (8 trials), "Avian Influenza" (4 trials), "Influenza Immunisation" (3 trials), "Influenza" (2 trials) and "SARS-CoV-2 Infection" (2 trials). Many other conditions were trialed in "Duke Human Vaccine Institute - Duke Vaccine and Trials Unit" in a lesser frequency.
Clinical Trials Intervention Types at Duke Human Vaccine Institute - Duke Vaccine and Trials Unit
Most popular intervention types in "Duke Human Vaccine Institute - Duke Vaccine and Trials Unit" are "Other" (16 trials), "Biological" (15 trials), "Drug" (15 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (14 trials), "AS03" (4 trials), "Remdesivir" (4 trials), "BNT162b2" (3 trials) and "Baricitinib" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Duke Human Vaccine Institute - Duke Vaccine and Trials Unit
The vast majority of trials in "Duke Human Vaccine Institute - Duke Vaccine and Trials Unit" are
23 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Duke Human Vaccine Institute - Duke Vaccine and Trials Unit
Currently, there are NaN active trials in "Duke Human Vaccine Institute - Duke Vaccine and Trials Unit".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 17 completed trials in Duke Human Vaccine Institute - Duke Vaccine and Trials Unit,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Duke Human Vaccine Institute - Duke Vaccine and Trials Unit, 10 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".